A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Falgas A, Lazaro-Gorines R, Zanetti SR, Rubio-Perez L, et al. Blood 2025 Mar 16:blood.2024025440. doi: 10.1182/blood.2024025440.

Read + Share

Amedeo Smart

Independent Medical Education

Falgas A, Lazaro-Gorines R, Zanetti SR, Rubio-Perez L, et al. A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Blood 2025 Mar 16:blood.2024025440. doi: 10.1182/blood.2024025440.
PMID: 40090006